Overview of Blockbuster Drugs in Oncology Approved in 2022, in the Pipeline for Approval in 2023
May 10th 2022Ray Tancredi, divisional vice president of Specialty Pharmacy, Development & Brand Rx/Vaccine Purchasing at Walgreens, discusses blockbuster drugs in the oncology space that have been approved this year or may be hitting the market soon.
Watch